REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
22/06/2026
Voltar para busca
Dado oficial do USPTO
B
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
45
Atualização mais recente
23/06/2026
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5
Data de depósito
20/09/2018
Data de registro
22/06/2021
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
22/06/2021
Última transação
23/06/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use, Foreign priority
Código do desenho
3
Tipo de titular
99
Localização do titular
Guangzhou, CN
Examinador
EVANKO, PATRICIA MALESARDI
Unidade examinadora
N10
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of a stylized letter "B" having an upward and forward-curving tail that terminates at a star; the letter "B" being a darker shading and the tail being a lighter shading; the letter "B" containing cross-hatching in a lighter shade.
Titulares e representantes
Titulares
Bostal Drug Delivery Co., Ltd.
Representantes
Kevin S. Costanza SEED IP LAW GROUP LLP
Classificação técnica
Classes Nice
Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical drugs for treatment of infectious diseases; Chewing gum for medical purposes; ß-blockers; Drugs for medical purposesvalsartan; Antioxidant drugsantioxidant food supplements; Pre-filled syringes for medical purposes filled with pharmaceutical preparationspharmaceutical preparations for treating nauseacancerhypertensionheart diseasehepatitisrheumatoid arthritisinflammationinsomnianephropathyhepatopathyParkinson's diseaseinsomniaoveractive bladderoculopathyencephalopathyotopathystomatopathyrhinopathysplenopathypulmonary diseasedermopathyencephalopathyosteopathyhemopathyendocrinopathydiabetesimmunological diseasesrespiratory diseases; Nutraceutical preparations for therapeutic or medical purposesnutraceuticals for the treatment of nauseacancerhypertensionheart diseasehepatitisrheumatoid arthritisinflammationinsomnianephropathyhepatopathyParkinson's diseaseinsomniaoveractive bladderoculopathyencephalopathyotopathystomatopathyrhinopathysplenopathypulmonary diseasedermopathyencephalopathyosteopathyhemopathyendocrinopathydiabetesimmunological diseasesrespiratory diseases; Chemical preparations for medical purposes for the treatment of illnesses or conditionsnauseacancerhypertensionheart diseasehepatitisrheumatoid arthritisinflammationinsomnianephropathyhepatopathyParkinson's diseaseinsomniaoveractive bladderoculopathyencephalopathyotopathystomatopathyrhinopathysplenopathypulmonary diseasedermopathyencephalopathyosteopathyhemopathyendocrinopathydiabetesimmunological diseasesrespiratory diseases; Pharmaceutical preparations for the treatment of illnesses or conditionsnauseacancerhypertensionheart diseasehepatitisrheumatoid arthritisinflammationinsomnianephropathyhepatopathyParkinson's diseaseinsomniaoveractive bladderoculopathyencephalopathyotopathystomatopathyrhinopathysplenopathypulmonary diseasedermopathyencephalopathyosteopathyhemopathyendocrinopathydiabetesimmunological diseasesrespiratory diseases
Publicações
Histórico de despachos e eventos da marca no USPTO.
45 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
22/06/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/04/2021
PUBO
PUBLISHED FOR OPPOSITION
06/04/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
17/03/2021
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
04/03/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
25/02/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
25/02/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
25/02/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
25/02/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
25/02/2021
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
22/02/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
22/02/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
20/02/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
19/02/2021
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
19/02/2021
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
21/08/2020
GNFR
FINAL REFUSAL E-MAILED
21/08/2020
CNFR
FINAL REFUSAL WRITTEN
21/08/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
17/08/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
17/08/2020
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
10/08/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
28/03/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
28/03/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
28/03/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
28/03/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
28/03/2020
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
17/02/2020
GNSI
INQUIRY TO SUSPENSION E-MAILED
17/02/2020
CNSI
SUSPENSION INQUIRY WRITTEN
17/02/2020
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
30/01/2020
ALIE
ASSIGNED TO LIE
17/01/2020
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
01/07/2019
GNSL
LETTER OF SUSPENSION E-MAILED
01/07/2019
CNSL
SUSPENSION LETTER WRITTEN
01/07/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
21/06/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
20/06/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
20/06/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
21/12/2018
GNRT
NON-FINAL ACTION E-MAILED
21/12/2018
CNRT
NON-FINAL ACTION WRITTEN
21/12/2018
DOCK
ASSIGNED TO EXAMINER
21/12/2018
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
27/09/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
26/09/2018
NWAP
NEW APPLICATION ENTERED
24/09/2018
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace B ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.